Calcium+Company expands with acquisition of CSG Health Group
The leading scientific communications group expands capabilities and resources of the Vitamin MD division.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
FDA warns about compounded versions of Novo Nordisk’s Ozempic, Wegovy
/in FDA/Regulatory, R&DThe FDA has warned that drug compounders are selling products that falsely claim to contain semaglutide, the same active ingredient as Novo Nordisk’s blockbuster diabetes and obesity drugs Ozempic and Wegovy their oral sibling Rybelsus.
U.S. Supreme Court gives boost to whistleblowers in drug pricing case
/in Business, TherapeuticsThe U.S. Supreme Court on Thursday gave a boost to whistleblowers in their bid to revive lawsuits accusing pharmacy operators of knowingly overbilling government health insurance programs for prescription drugs at taxpayers’ expense.
Medicare will require data on patient use for approved Alzheimer’s drugs
/in Business, FDA/Regulatory, TherapeuticsThe Medicare health plan will cover new Alzheimer’s drugs after full U.S. approval for patients who participate in a health agency database, a move that expands on conditional coverage terms but companies have said that would limit use.
AstraZeneca to stop developing Crohn’s disease drug
/in R&D, TherapeuticsBritish drugmaker AstraZeneca (AZN.L) said on Thursday it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis.
Coherus BioSciences to launch Humira biosimilar at 85% discount
/in Business, TherapeuticsCoherus BioSciences Inc. said on Thursday it plans to launch a biosimilar of AbbVie Inc’s (ABBV.N) Humira in July at a list price of $995 per carton, representing a discount of about 85% from the blockbuster arthritis drug.
FDA approves Pfizer’s RSV vaccine for older adults
/in FDA/Regulatory, Health, TherapeuticsThe FDA has approved Pfizer’s respiratory syncytial virus vaccine, henceforth to carry the brand name Abrysvo, to prevent lower respiratory tract disease in older adults aged 60 years and above, the company announced Wednesday.
EVERSANA forms strategic alliance with China Resource Pharmaceutical Commercial Group to bring new novel treatments to patients globally
/in Marketing & AdvertisingTogether, the two organizations will collaborate on helping expand access to innovative healthcare solutions that are available both in and outside of China to ultimately help more patients globally discover new treatment options for a variety of disease states.
Exclusive: Roche looking to sell or shut down California biologic drug plant
/in Business, TherapeuticsSwiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029, according to e-mailed letters to workers seen by Reuters on Wednesday.
FDA flags issues at Coherus partner’s China plant for cancer drug
/in Business, FDA/Regulatory, R&DCoherus BioSciences Inc. said on Wednesday the U.S. Food and Drug Administration (FDA) had flagged three observations at its partner’s manufacturing site in China when the agency was conducting inspections related to its experimental cancer drug.